Antivascular Endothelial Growth Factors in Age-Related Macular Degeneration

Anti-VEGF - Developments in Ophthalmology ◽

10.1159/000320007 ◽

2010 ◽

pp. 21-38 ◽

Author(s):

Ursula Schmidt-Erfurth ◽

Andreas Pollreisz ◽

Christoph Mitsch ◽

Matthias Bolz

Keyword(s):

Growth Factors ◽

Macular Degeneration ◽

Age Related Macular Degeneration ◽

Age Related ◽

Endothelial Growth Factors

Download Full-text

Anti-vascular endothelial growth factors treatment of wet age-related macular degeneration: from neurophysiology to cost-effectiveness

Acta Ophthalmologica ◽

10.1111/aos.13706 ◽

2018 ◽

Vol 96 ◽

pp. 1-46 ◽

Author(s):

Pasi Vottonen

Keyword(s):

Growth Factors ◽

Cost Effectiveness ◽

Macular Degeneration ◽

Age Related Macular Degeneration ◽

Vascular Endothelial Growth Factors ◽

Vascular Endothelial ◽

Age Related ◽

Endothelial Growth Factors

Download Full-text

Bevacizumab and Triamcinolone Acetonide for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Antivascular Endothelial Growth Factors

Journal of Ocular Pharmacology and Therapeutics ◽

10.1089/jop.2012.0173 ◽

2013 ◽

Vol 29 (4) ◽

pp. 437-441 ◽

Author(s):

Daniele Veritti ◽

Valentina Sarao ◽

Paolo Lanzetta

Keyword(s):

Growth Factors ◽

Macular Degeneration ◽

Triamcinolone Acetonide ◽

Choroidal Neovascularization ◽

Age Related Macular Degeneration ◽

Age Related ◽

Endothelial Growth Factors

Download Full-text

DI-035 Intravitreal aflibercept injections for treating wet age related macular degeneration unresponsive to other antivascular endothelial growth factors: Initial experience in routine clinical practice

European Journal of Hospital Pharmacy ◽

10.1136/ejhpharm-2016-000875.302 ◽

2016 ◽

Vol 23 (Suppl 1) ◽

pp. A133.2-A133

Author(s):

MD Toscano ◽

V Vázquez ◽

AB Guisado ◽

E Prado ◽

L Herrrera

Keyword(s):

Clinical Practice ◽

Growth Factors ◽

Macular Degeneration ◽

Routine Clinical Practice ◽

Age Related Macular Degeneration ◽

Initial Experience ◽

Age Related ◽

Intravitreal Aflibercept ◽

Endothelial Growth Factors

Download Full-text

Real-world outcomes of intravitreal antivascular endothelial growth factors for neovascular age-related macular degeneration in Taiwan: A 4-year longitudinal study

Taiwan Journal of Ophthalmology ◽

10.4103/tjo.tjo_34_19 ◽

2019 ◽

Vol 9 (4) ◽

pp. 249

Author(s):

San-Ni Chen ◽

BenjaminChi-Lan Yang ◽

TerryYu-Hung Chou

Keyword(s):

Growth Factors ◽

Longitudinal Study ◽

Macular Degeneration ◽

Age Related Macular Degeneration ◽

Age Related ◽

Endothelial Growth Factors

Download Full-text

Systemic side effects after intravitreal administration of antivascular endothelial growth factors for neovascular age-related macular degeneration

Spektrum der Augenheilkunde ◽

10.1007/s00717-017-0384-3 ◽

2017 ◽

Vol 33 (5) ◽

pp. 110-116

Author(s):

Alina Popa-Cherecheanu ◽

Raluca Iancu ◽

Danut Vasile ◽

Ruxandra Pirvulescu ◽

Aida Geamanu ◽

...

Keyword(s):

Growth Factors ◽

Side Effects ◽

Macular Degeneration ◽

Age Related Macular Degeneration ◽

Age Related ◽

Systemic Side Effects ◽

Endothelial Growth Factors

Download Full-text

Switching Anti-Vascular Endothelial Growth Factors in Refractory Neovascular Age-Related Macular Degeneration

Ophthalmic Surgery Lasers and Imaging Retina ◽

10.3928/23258160-20180221-03 ◽

2018 ◽

Vol 49 (3) ◽

pp. 166-170 ◽

Author(s):

Mohammed Ashraf ◽

Touka Banaee ◽

Fabiana Q. Silva ◽

Rishi P. Singh

Keyword(s):

Growth Factors ◽

Macular Degeneration ◽

Age Related Macular Degeneration ◽

Vascular Endothelial Growth Factors ◽

Vascular Endothelial ◽

Age Related ◽

Endothelial Growth Factors

Download Full-text

Bruch’s membrane diffusivity for vascular endothelial growth factors may explain variable response to wet age-related macular degeneration treatment: Clinical implications

Medical Hypotheses ◽

10.1016/j.mehy.2014.10.022 ◽

2014 ◽

Vol 83 (6) ◽

pp. 835-837 ◽

Author(s):

Ram R. Peddada

Keyword(s):

Growth Factors ◽

Macular Degeneration ◽

Age Related Macular Degeneration ◽

Vascular Endothelial Growth Factors ◽

Clinical Implications ◽

Vascular Endothelial ◽

Variable Response ◽

Bruch’S Membrane ◽

Age Related ◽

Endothelial Growth Factors

Download Full-text

Exploration of real‐world outcomes and treatment patterns in patients treated with anti‐vascular endothelial growth factors for neovascular age‐related macular degeneration in Sweden

Acta Ophthalmologica ◽

10.1111/aos.15025 ◽

2021 ◽

Author(s):

Marion Schroeder ◽

Inger Westborg ◽

Caroline Fluur ◽

Rasmus Olsen ◽

Monica Lövestam‐Adrian

Keyword(s):

Growth Factors ◽

Macular Degeneration ◽

Treatment Patterns ◽

Age Related Macular Degeneration ◽

Vascular Endothelial Growth Factors ◽

Vascular Endothelial ◽

Age Related ◽

Endothelial Growth Factors

Download Full-text

For people with neovascular age-related macular degeneration (AMD), what are the effects of anti-vascular endothelial growth factors (anti-VEGFs)?

Cochrane Clinical Answers ◽

10.1002/cca.2499 ◽

2019 ◽

Author(s):

Jane Burch ◽

Sarah Anderson

Keyword(s):

Growth Factors ◽

Macular Degeneration ◽

Age Related Macular Degeneration ◽

Vascular Endothelial Growth Factors ◽

Vascular Endothelial ◽

Age Related ◽

Endothelial Growth Factors

Download Full-text

Macular atrophy in neovascular age related macular degeneration

Journal of Clinical Review & Case Reports ◽

10.33140/jcrc/04/01/00008 ◽

2019 ◽

Vol 4 (1) ◽

Keyword(s):

Growth Factors ◽

Macular Degeneration ◽

Age Related Macular Degeneration ◽

Vascular Endothelial Growth Factors ◽

Vascular Endothelial ◽

Industrialized Countries ◽

Macular Atrophy ◽

Age Related ◽

Endothelial Growth Factors

Age related macular degeneration has been the leading cause of blindness in industrialized countries. Various treatments have been developed in the last few years. The pinnacle of treatment of neovascular age related macular degenerations have been anti-vascular endothelial growth factors. This article is an opinion on macular atrophy developing in neovascular age related macular degeneration.

Download Full-text